Richartz-Salzburger E, Stransky E, Laske C, Köhler N
Universitätsklinik für Psychiatrie und Psychotherapie, Tübingen, Tübingen, Deutschland.
Nervenarzt. 2010 Jul;81(7):837-43. doi: 10.1007/s00115-009-2918-7.
While the familial form of Alzheimer's disease (AD) is known to be entirely inherited, the etiopathogenesis of the most common late-onset form of Alzheimer's disease still remains unresolved. Among various factors, aging seems to be one of the most prominent risk factors. Moreover, a large body of evidence points to the contribution of immunological alterations in AD. The involvement of inflammatory factors in the etiopathology has been widely discussed. Moreover, an impairment of certain immune responses in AD has been observed. Presumably, premature immunosenescence may lead to inadequate immune reactions. Against this background, the development of different immunotherapeutic strategies seems to be a promising challenge for future research.
虽然已知家族性阿尔茨海默病(AD)完全是遗传性的,但最常见的晚发型阿尔茨海默病的病因发病机制仍未得到解决。在各种因素中,衰老似乎是最突出的危险因素之一。此外,大量证据表明免疫改变在AD中起作用。炎症因子在病因病理学中的作用已得到广泛讨论。此外,已观察到AD中某些免疫反应受损。据推测,过早的免疫衰老可能导致免疫反应不足。在此背景下,开发不同的免疫治疗策略似乎是未来研究的一个有前景的挑战。